Peter Pang focuses on capital markets, private equity and cross-border mergers and acquisitions.

Highlights from Mr. Pang’s experience include representing:

Capital Markets

  • AMTD International Inc. in its US$200 million U.S. IPO and NYSE listing;
  • NIO Inc. in its US$1 billion U.S. IPO and NYSE listing;
  • the underwriters in the US$101 million U.S. IPO of Four Seasons Education (Cayman) Inc.;
  • China Renaissance Holdings Limited in its US$350 million Hong Kong IPO;
  • VCREDIT Holdings Limited in its US$163 million Hong Kong IPO;
  • Yixin Group Limited in its US$870 million Hong Kong IPO;
  • Baidu, Inc. in its US$1.25 billion SEC-registered investment-grade note offerings;
  • Bitauto Holdings Limited in its US$150 million private placement of convertible notes;
  • International, Ltd. in its US$2.6 billion concurrent SEC-registered follow-on ADS offering and Rule 144A/Regulation S offerings of convertible notes and ordinary shares;
  • Weibo Corporation in its US$800 million SEC-registered investment-grade note offering;
  • YY Inc. in its US$463 million SEC-registered follow-on ADS offering; and
  • AMTD International Inc., International, Ltd., NIO Inc. and Vipshop Holdings Limited in their U.S. securities law compliance, corporate governance and periodic reporting.

M&A and Private Equity

  • Capital Group Private Markets in its investment with GL Capital for approximately 29 percent stake in JINXIN Medical Investment Group Limited in June 2018;
  • NIO Inc. in its Series D preferred share financing in November 2017;
  • International, Ltd. in its £1.4 billion acquisition of UK-based Skyscanner Holdings Limited through cross-border tender offer; US$213 million convertible notes investments in MakeMyTrip Limited; and in its US$1 billion convertible notes investments by The Priceline Group Inc. and Hillhouse Capital;
  • National Silicon Industry Group in its €170 million takeover of Okmetic Oyj through a voluntary public tender offer in November 2016;
  • Tencent Holdings Limited in its US$69 million acquisition, as part of an investor group including Huayi Brothers and other investors, of a 51 percent interest in China Jiuhao Health Industry Corporation; and
  • The Carlyle Group in its US$64 million investment for a 15.7 percent stake in Zhongmei Healthcare Group Limited in January 2016.



  • LL.M., Duke Law School, 2006
  • LL.M., New York University School of Law, 2005
  • J.D., Fordham University School of Law, 2010
  • LL.B., Shanghai International Studies University, 2004


  • New York

Peter Pang